You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Breaking news on Genetics & Genomics business, policy & funding.
The company believes the pandemic will accelerate the adoption of its cancer diagnostics as patients and doctors look for faster and more convenient tests.
The seven technologies feature different methods, including CRISPR and microfluidics, and can be performed in many settings and with a variety of sample types.
The test, which has Emergency Use Authorization from the US Food and Drug Administration, is designed to detect the SARS-CoV-2 ORF1ab, N, and E genes.
In a local coverage article, Medicare contractors in the MolDx program added prostate cancer to the covered indications for the test.
According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.
Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.
Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.
In Science this week: chromatin accessibility of microglia during fetal development, and more.